Showing results (511-520 of 589) with videos related to
Sort By:
Pageof 59
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2019
Imaging the Renner-Teller effect using laser-induced electron diffractionKasra Amini, Michele Sclafani, Tobias Steinle, et al.Cancer Research|January 18, 2023
NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid CellsLi Guan, Dhanya K Nambiar, Hongbin Cao, et al.Bioorganic & Medicinal Chemistry Letters|January 22, 2026
Nitric oxide and α-glucosidase inhibitors from Ludwigia adscendens: An integrated in vitro and in silico studyThi Bich Hanh Dam, Truong Nhan Ngu, Phu Chi Hieu Truong, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002Rathan M Subramaniam, Lyudmila DeMora, Min Yao, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2016
Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR)Aadel A Chaudhuri, Michael S Binkley, Joseph Rigdon, et al.Proceedings of the National Academy of Sciences of the United States of America|May 26, 2018
Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydesJulie P Saiki, Hongbin Cao, Lauren D Van Wassenhove, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.International Journal of Molecular Sciences|February 25, 2023
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic SyndromesGrace A Ward, Robert P Dalton, Benjamin S Meyer, et al.Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.Pageof 59